This is a demo store. No orders will be fulfilled.
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
12 Aug 2015  |  Global  |  Market Research
Singapore Contract Research Organization Market
Singapore will Remain in the Global Spotlight as the Strategic Hub of the CRO Market in APAC.
The research service assesses marketed and investigational products, as well as combination regimens, for asthma and chronic obstructive pulmonary disease (COPD). Segmentation by drug class is provided along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiolo...
$1,500.00 -
07 Aug 2015  |  Global  |  Market Research
Indian Contract Research Organization (CRO) Market
The Evolving Regulatory Scenario is Likely to Boost Market Growth
This study assesses marketed and in-research products and combination regimens for the lung cancer therapeutics market. Segmentation by drug class is provided, along with additional supporting information such as clinical trial timelines and results, historical and projected launch timelines, and epidemiology. The marketed and pipeline products are...
$1,500.00 -
03 Aug 2015  |  Europe  |  Market Research
The South Korean Contract Research Organization Market
Government Initiatives Offer Powerful Boost to the Clinical Trials Industry
Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...
$1,500.00 -
20 May 2015  |  Global  |  Market Research
A Competitive Analysis of the Global Acute Coronary Syndrome (ACS) Therapeutics Market
Launch of Promising Late-stage Anti-hypertensive Drugs to Drive Growth of Branded ACS Therapeutics
China is predicted to become the third-largest pharmaceutical market in the world by the end of 2013 due to the governments considerable investment in the healthcare industry and the populations unmet healthcare needs. The life sciences industry is broad and involves a wide range of disciplines. This research service focuses on the trends and mar...
$3,950.00 -
27 Mar 2015  |  Europe  |  Market Research
Western European Contrast Auto-injectors Market
Better Workflow Integration Provides Increasing Market Potential
The Western European contrast auto-injectors market is currently growing at steady rate of 4-5%. Although economic uncertainty and budgetary constraints have slowed the market in certain countries, the invasive technology of the auto-injector has overwhelmed the restraints due to its key role in contrast delivery management. This research service c...
$3,950.00 -
17 Mar 2015  |  Global  |  Market Research
Analysis of the Global Diabetes Drug Delivery Market
Future Options for End Users
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and Euro...
$4,950.00 -
09 Mar 2015  |  Europe  |  Market Research
Western and Eastern European Custom Procedure Trays and Packs (CPTP) Market
Ripe Opportunities Exist Within the Growing Landscape
The Western and Eastern European Custom Procedure Trays and Packs (CPTP) market is growing rapidly. CPTPs offer off-the-shelf convenience for hospitals, reduce costs, and lead to more-efficient operating rooms with faster turnaround times. The enforcement of stricter infection control measures has also greatly aided the adoption of CPTPs, as clinic...
$3,950.00 -
05 Mar 2015  |  Global  |  Market Research
Growth Drivers for Biomarkers in Healthcare
Managing Success in the Biomarker Industry—Challenges and Opportunities
Biomarkers are no longer mere tools used to measure the criteria of a biological process characteristic. They are being increasingly used in patient stratification and customised medical interventions. This research service presents an overview and analysis of the global biomarker market. It provides revenue forecasts for biomarker on technological...
$2,450.00 -
26 Feb 2015  |  Global  |  Market Research
Regulatory Trends in the US Pharma/Biotech Industry
Efficiency of the FDA Review Process Expedites Access to Care
This research service focuses on existing therapeutics and product pipeline for the treatment of Parkinsons Disease using Dopamine Replacement Therapies, Dopamine Agonists, MAO-inhibitors, COMT-inhibitors and other pharamcolgical approaches for current global interest. This research service does not cover vaccines. A product and pipeline assessmen...
$1,500.00 -
04 Feb 2015  |  Global  |  Market Research
Vital Signs - The Analysts Perspective - January 2015 Issue
This issue of Vital Signs, released on February 4, 2014, discusses Roches collaboration with Foundation Medicine, Novartis potential anti-aging drug, and DNA Electronics; acquisition of nanoMR, Inc.
$500.00